Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
Rovelizumab (anti-CD11a&CD18) - Primary antibody, specific to ITGAL; ITGB2, Human IgG4, Antibody of integrin; alpha L subunit (antigen CD11A (p180); lymphocyte function-associated antigen 1; alpha polypeptide);Antibody of integrin; beta 2 subunit (complem, Antibody of integrin; alpha L subunit (antigen CD11A (p180); lymphocyte function-associated antigen 1; alpha polypeptide);Antibody of integrin; beta 2 subunit (complement component 3 receptor 3 and 4 subunit)
- Host species: Human
- Reactive species: Human
- Isotype: Human IgG4
- Conjugation: Unconjugated
In stock
Item Number
Ab175649
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175649-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$69.90
|
|
|
Ab175649-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$339.90
|
|
|
Ab175649-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$869.90
|
|
|
Ab175649-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,379.90
|
|
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated